Cowen Inc’s Iovance Biotherapeutics IOVA Stock Holding History

Cowen Inc’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$85K	Buy	+30,900	New	+$465K	0.01%	303

Other funds holding IOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Cowen Inc's IOVA Position: Q2 2015 in Review

Cowen Inc sold out of Iovance Biotherapeutics (IOVA) in Q2 2015, closing a stake of 33,650 shares — an estimated $408K sold.

Cowen Inc first reported a position in IOVA in Q1 2015 and held it in 1 quarter. The position peaked at $408K in Q1 2015. 86 funds tracked by Wall St. Rank hold IOVA as of Q2 2015.

Cowen Inc reported no remaining Iovance Biotherapeutics position as of Q2 2015 after selling out during the quarter.
Cowen Inc sold 33,650 Iovance Biotherapeutics shares in Q2 2015, an estimated $408K.
Cowen Inc first reported a position in Iovance Biotherapeutics in Q1 2015 and held it in 1 quarter.
Cowen Inc's Iovance Biotherapeutics position peaked at $408K in Q1 2015.
86 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2015.

Based on Cowen Inc's 13F filing for Q2 2015, filed 14 Aug 2015.